Fundz

Inter Vene, Inc. reported raising $2.16 Million in an initial SEC Form D filing, from an offering of $3 Million

PRIVATEJun 07, 2017$2.2M of $3M raised

Amount Raised

$2.16 Million

$2.16 Million sold, per SEC Form D (first sale Jun 7, 2017)

Round Type

Seed

South San FranciscoHealthcare

Quick answer

InterVene raised $2.16 Million in a Seed round, dated June 7, 2017. InterVene is based in South San Francisco, California, United States.

How much did InterVene raise?
InterVene raised $2.16 Million in a Seed round on June 7, 2017.
What does InterVene do?
InterVene is a medical device start-up company reinventing the way physicians treat severe venous disease in the legs.
Where is InterVene based and how big is it?
InterVene is based in South San Francisco, California, United States.
Who are the decision-makers at InterVene?
Fundz holds 1 contact at InterVene. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Healthcare around the same time

Companies in the same sectors as InterVene that raised within 45 days of this round, from Fundz verified event records.

  • JumpStart Fertility, Inc. raised $500K (Seed) on July 21, 2017.
  • Wellfount, Corp raised $12M on July 20, 2017.
  • Ancora Medical, Inc. raised $817K (Seed) on July 20, 2017.
  • Colorescience Inc raised $15M on July 20, 2017.
  • Rennova Health, Inc. raised $4.1M (Seed) on July 20, 2017.
  • Streamex Corp. raised $1.6M on July 20, 2017.

Who to call at InterVene, and when

A new round usually means InterVene is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day InterVene raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at InterVene, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at InterVene. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

InterVene

Location

South San Francisco, California, United States

About

InterVene is a medical device start-up company reinventing the way physicians treat severe venous disease in the legs. InterVene's BlueLeaf(TM) Endovenous Valve Formation System represents the first ever non-implantable, endovenous approach to deep vein valve failure. This technology allows physicians to create new vein valves for patients who are unable to efficiently pump blood out of their legs and back to their heart. Millions of Americans currently suffer from painful venous stasis ulcers (VSU’s) and other costly and devastating symptoms, yet no minimally invasive therapy exists to treat deep vein valve failure, one of the most prevalent underlying causes of these symptoms. InterVene plans to change that.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment InterVene raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Verified contacts5 people are listed at InterVene. We don't have their email yet.See plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for InterVene's next move

See what Strategic adds

InterVene raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.